Breaking News Instant updates and real-time market news.

GLW

Corning

$27.99 /

-0.58 (-2.03%)

07:18
01/29/20
01/29
07:18
01/29/20
07:18

Corning sees 6%-8% compound annual sales growth through 2023

Corning remains confident in its Strategy & Growth Framework goals. Under the Framework, the company will continue to focus its portfolio and utilize its financial strength to capture significant organic growth and create additional value for shareholders over the next four years. Through 2023, Corning expects to deliver 6% to 8% compound annual sales growth and 12% to 15% compound annual earnings per share growth while investing $10B to $12B in RD&E, capital and mergers, and acquisitions. The company also plans to expand operating margin and ROIC, and deliver $8B to $10B to shareholders, including annual dividend per share increases of at least 10%. "To deliver our Strategy & Growth Framework goals, we expect to add an incremental $3 billion to $4 billion in annual sales and improve profitability by the end of 2023. We are confident in our ability to achieve these goals because we are closely aligned with major growth drivers in each of our Market-Access Platforms, positioning us to create and sell into new product categories. In short, we plan to drive more Corning technologies into the products consumers already buy," CEO Wendell Weeks said. "This provides a mechanism for us to grow - even in challenging environments.We believe the benefits of this approach are already manifesting themselves. In Automotive we grew Environmental sales 16% while car sales were down. In Mobile Consumer Electronics, we grew Specialty Materials sales 8% while smartphone units were down. In Life Sciences, we exceeded industry growth on the strength of new products for cell culture and gene therapy.

  • 29

    Jan

  • 11

    Feb

GLW Corning
$27.99 /

-0.58 (-2.03%)

01/08/20 Morgan Stanley
Morgan Stanley stepping away from Corning 'for now,' downgrades to Equal Weight
01/08/20 Morgan Stanley
Corning downgraded to Equal Weight from Overweight at Morgan Stanley
10/30/19 Deutsche Bank
Corning downgraded to Hold from Buy at Deutsche Bank
10/03/19 H.C. Wainwright
Cesca Therapeutics price target raised to $7.50 from $6.50 at H.C. Wainwright

TODAY'S FREE FLY STORIES

Upgrade
National Storage upgraded to Hold from Sell at SunTrust » 07:01
03/31/20
03/31
07:01
03/31/20
07:01
NSA

National Storage

$28.46 /

+1.94 (+7.32%)

SunTrust analyst Ki Bin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Barclays double upgrades OMA, downgrades GAP Airports » 07:00
03/31/20
03/31
07:00
03/31/20
07:00
OMAB

OMA

$26.53 /

-0.49 (-1.81%)

, PAC

GAP Airports

$54.98 /

-1.3 (-2.31%)

Barclays analyst Pablo…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Visa sees Q2 non-GAAP EPS growth in high end of mid-single digits percent range » 07:00
03/31/20
03/31
07:00
03/31/20
07:00
V

Visa

$165.53 /

+4.06 (+2.51%)

In a regulatory filing…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Range Resources reduces FY20 capital budget to $430 from $520 » 06:59
03/31/20
03/31
06:59
03/31/20
06:59
RRC

Range Resources

$2.33 /

+0.165 (+7.64%)

Range Resources announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Pennsylvania REIT withdraws FY20 financial outlook due to COVID-19 uncertainty  06:58
03/31/20
03/31
06:58
03/31/20
06:58
PEI

Pennsylvania REIT

$0.89 /

-0.0302 (-3.28%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Corteva upgraded to Positive from Neutral at Susquehanna » 06:57
03/31/20
03/31
06:57
03/31/20
06:57
CTVA

Corteva

$24.12 /

+0.92 (+3.97%)

Susquehanna analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Xenia Hotels provides business update amid COVID-19 pandemic » 06:56
03/31/20
03/31
06:56
03/31/20
06:56
XHR

Xenia Hotels

$9.99 /

+0.04 (+0.40%)

Xenia Hotels provided an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Cavco Industries continues to operate substantially all its facilities » 06:56
03/31/20
03/31
06:56
03/31/20
06:56
CVCO

Cavco Industries

$148.20 /

-7.835 (-5.02%)

Cavco Industries provided…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Sanderson upgraded to Overweight with $168 price target at Barclays » 06:55
03/31/20
03/31
06:55
03/31/20
06:55
SAFM

Sanderson Farms

$122.16 /

+2.98 (+2.50%)

Barclays analyst Benjamin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Marfrig upgraded to Overweight from Equal Weight at Barclays » 06:53
03/31/20
03/31
06:53
03/31/20
06:53
MRRTY

Marfrig

$0.00 /

+ (+0.00%)

Barclays analyst Benjamin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Wendy's upgraded to Outperform from Neutral at Wedbush » 06:52
03/31/20
03/31
06:52
03/31/20
06:52
WEN

Wendy's

$14.95 /

+0.875 (+6.22%)

Wedbush analyst Nick…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Brookfield Renewable enters into automatic purchase plan with its broker » 06:52
03/31/20
03/31
06:52
03/31/20
06:52
BEP

Brookfield Renewable

$41.72 /

+0.56 (+1.36%)

Brookfield Renewable…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Great Western downgraded to Neutral from Buy at DA Davidson » 06:51
03/31/20
03/31
06:51
03/31/20
06:51
GWB

Great Western

$20.83 /

+0.3 (+1.46%)

DA Davidson analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Venus Concept downgraded to Perform from Outperform at Oppenheimer » 06:51
03/31/20
03/31
06:51
03/31/20
06:51
VERO

Venus Concept

$3.65 /

-0.05 (-1.35%)

Oppenheimer analyst Suraj…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
H&R Block price target lowered to $17 from $19 at BMO Capital » 06:51
03/31/20
03/31
06:51
03/31/20
06:51
HRB

H&R Block

$14.00 /

-1.05 (-6.98%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
The Buckle extends closure of all brick and mortar stores indefinitely » 06:51
03/31/20
03/31
06:51
03/31/20
06:51
BKE

The Buckle

$14.96 /

-0.38 (-2.48%)

The Buckle announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Downgrade
Goldman downgrades Amarin, cuts target to $4 from $27 after patent ruling » 06:51
03/31/20
03/31
06:51
03/31/20
06:51
AMRN

Amarin

$13.59 /

+0.34 (+2.57%)

, RDY

Dr. Reddy's

$40.22 /

+1.65 (+4.28%)

, HKMPF

Hikma Pharmaceuticals

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Goldman Sachs analyst Paul Choi downgraded Amarin (AMRN) to Neutral from Buy with a price target of $4, down from $27. The U.S. District Court for Nevada last night issued a ruling in favor of the generic manufacturers in the patent trial between Amarin and Dr. Reddy's (RDY) / Hikma Pharmaceuticals (HKMPF), Choi tells investors in a research note. As Amarin management considers various options, the near-term stock performance will be limited, pending clarity on FDA approval of the new drug filings, a future circuit court appeals decision, and how quickly and effectively the company monetizes the opportunity for Vascepa in international markets, Choi contends.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Target Hospitality reduces FY20 growth capital expenditures by 50% » 06:50
03/31/20
03/31
06:50
03/31/20
06:50
TH

Target Hospitality

$1.85 /

-0.08 (-4.15%)

Target has not…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Wendy's upgraded to Outperform from Market Perform at Cowen » 06:50
03/31/20
03/31
06:50
03/31/20
06:50
WEN

Wendy's

$14.95 /

+0.875 (+6.22%)

Cowen analyst Andrew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Ultrapar upgraded to Buy from Neutral at BofA » 06:49
03/31/20
03/31
06:49
03/31/20
06:49
UGP

Ultrapar

$2.43 /

-0.105 (-4.14%)

BofA analyst Frank McGann…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Target Hospitality implements response plan to mitigate spread of COVID-19 » 06:49
03/31/20
03/31
06:49
03/31/20
06:49
TH

Target Hospitality

$1.85 /

-0.08 (-4.15%)

Target has implemented a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
BWX Technologies awarded $128M in contract options by U.S. Navy » 06:48
03/31/20
03/31
06:48
03/31/20
06:48
BWXT

BWX Technologies

$47.43 /

+0.31 (+0.66%)

BWX Technologies…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Amarin downgraded to Neutral from Buy at Goldman Sachs » 06:47
03/31/20
03/31
06:47
03/31/20
06:47
AMRN

Amarin

$13.59 /

+0.34 (+2.57%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Target Hospitality withdraws FY20 guidance » 06:46
03/31/20
03/31
06:46
03/31/20
06:46
TH

Target Hospitality

$1.85 /

-0.08 (-4.15%)

The spread of COVID-19…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
The Stars Group announces UK CMA clearance for combination » 06:46
03/31/20
03/31
06:46
03/31/20
06:46
TSG

The Stars Group

$18.18 /

+0.38 (+2.13%)

The Stars Group welcomes…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.